Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App




Real-Time PCR Kit Enables Specific Identification and Differentiation of Rhinovirus and/or Enterovirus

By LabMedica International staff writers
Posted on 21 Jul 2023
Print article
Image: The VIASURE Rhinovirus + Enterovirus Real Time PCR Detection Kit (Photo courtesy of CerTest)
Image: The VIASURE Rhinovirus + Enterovirus Real Time PCR Detection Kit (Photo courtesy of CerTest)

Echovirus 11 (E-11), part of the Enterovirus genus, is associated with a variety of health conditions, from mild non-specific symptoms to severe systemic and neurological disorders like skin rashes, fever, meningitis, encephalitis, and acute flaccid paralysis (AFP). It poses a significant threat to neonates and infants, leading to high rates of illness and death. E-11 can be transmitted from mother to child, making infection control a challenge. In neonates, these infections can cause severe inflammatory diseases, including acute hepatitis with coagulopathy.

Without a global enterovirus surveillance program, estimating the current prevalence of severe neonatal E-11 infections or the virus's circulation rate in the population is difficult. Only the most severe cases are likely to be detected through active sample testing and typing efforts without enterovirus surveillance. Furthermore, there may be unreported and undiagnosed cases of severe neonatal enterovirus infection since non-polio enterovirus infection is often not a reportable disease. Now, a real-time PCR test can quickly and accurately identify as well as differentiate Rhinovirus and/or Enterovirus, allowing for personalized treatment and proper medical care.

CerTest Biotec’s (Zaragoza, Spain) VIASURE Rhinovirus + Enterovirus real-time PCR kit is specifically designed for the identification and differentiation of Rhinovirus and/or Enterovirus. The primer/probe design enables the detection of Enterovirus (Echovirus-11 (E-11)), facilitating early and precise diagnosis of this viral infection. The qPCR (real-time PCR) method is highly sensitive and specific, delivering reliable and accurate results quickly. The VIASURE kit offers considerable benefits in diagnosing Rhinovirus and Enterovirus infections. By specifically detecting Echovirus-11, it aids in distinguishing it from other Enterovirus family members, ensuring a more comprehensive and accurate infection assessment.

Early detection of Echovirus-11 is vital for appropriate and timely clinical management of affected patients. This includes identifying outbreaks, isolating and treating affected cases adequately, and monitoring the virus spread to implement effective control and preventive measures. Moreover, the test’s ability to differentiate between Rhinovirus and Enterovirus is invaluable as these two virus families can present similar symptoms, but their clinical implications and treatments could vary. Accurate diagnosis allows for more personalized and appropriate patient care. The VIASURE Rhinovirus + Enterovirus real-time PCR kit serves as a crucial tool for rapid and precise viral infection diagnosis, especially in Echovirus-11 cases, significantly contributing to efficient public health and healthcare management.

Related Links:
CerTest Biotec

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.